S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in

Merrimack Pharmaceuticals Stock Forecast, Price & News

+0.04 (+0.53 %)
(As of 01/22/2021 12:00 AM ET)
Today's Range
Now: $7.56
50-Day Range
MA: $7.30
52-Week Range
Now: $7.56
Volume37,859 shs
Average Volume99,097 shs
Market Capitalization$101.15 million
P/E RatioN/A
Dividend YieldN/A
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is based in Cambridge, Massachusetts.
Merrimack Pharmaceuticals logo


Overall MarketRank

1.08 out of 5 stars

Medical Sector

931st out of 1,925 stocks

Pharmaceutical Preparations Industry

448th out of 773 stocks

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:MACK



Sales & Book Value

Annual SalesN/A
Book Value$1.30 per share


Net Income$-17,330,000.00


Market Cap$101.15 million
Next Earnings Date3/11/2021 (Estimated)
+0.04 (+0.53 %)
(As of 01/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MACK News and Ratings via Email

Sign-up to receive the latest news and ratings for MACK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Merrimack Pharmaceuticals (NASDAQ:MACK) Frequently Asked Questions

How has Merrimack Pharmaceuticals' stock been impacted by Coronavirus?

Merrimack Pharmaceuticals' stock was trading at $2.76 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MACK stock has increased by 173.9% and is now trading at $7.56.
View which stocks have been most impacted by COVID-19

What stocks does MarketBeat like better than Merrimack Pharmaceuticals?

Wall Street analysts have given Merrimack Pharmaceuticals a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Merrimack Pharmaceuticals wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Doug Parker's approval rating as Merrimack Pharmaceuticals' CEO?

1,448 employees have rated Merrimack Pharmaceuticals CEO Doug Parker on Glassdoor.com. Doug Parker has an approval rating of 60% among Merrimack Pharmaceuticals' employees. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is Merrimack Pharmaceuticals' next earnings date?

Merrimack Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Thursday, March 11th 2021.
View our earnings forecast for Merrimack Pharmaceuticals

How were Merrimack Pharmaceuticals' earnings last quarter?

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) released its quarterly earnings results on Thursday, November, 5th. The biopharmaceutical company reported ($0.08) EPS for the quarter.
View Merrimack Pharmaceuticals' earnings history

When did Merrimack Pharmaceuticals' stock split? How did Merrimack Pharmaceuticals' stock split work?

Merrimack Pharmaceuticals's stock reverse split on the morning of Wednesday, September 6th 2017. The 1-10 reverse split was announced on Thursday, August 31st 2017. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, September 5th 2017. An investor that had 100 shares of Merrimack Pharmaceuticals stock prior to the reverse split would have 10 shares after the split.

Are investors shorting Merrimack Pharmaceuticals?

Merrimack Pharmaceuticals saw a increase in short interest in December. As of December 31st, there was short interest totaling 911,400 shares, an increase of 39.1% from the December 15th total of 655,100 shares. Based on an average daily volume of 1,400,000 shares, the days-to-cover ratio is currently 0.7 days. Currently, 6.9% of the shares of the stock are sold short.
View Merrimack Pharmaceuticals' Short Interest

Who are some of Merrimack Pharmaceuticals' key competitors?

What other stocks do shareholders of Merrimack Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merrimack Pharmaceuticals investors own include Agenus (AGEN), Inovio Pharmaceuticals (INO), Rite Aid (RAD), Anavex Life Sciences (AVXL), Gilead Sciences (GILD), Novavax (NVAX), Exelixis (EXEL), Amicus Therapeutics (FOLD), Bausch Health Companies (BHC) and Verastem (VSTM).

Who are Merrimack Pharmaceuticals' key executives?

Merrimack Pharmaceuticals' management team includes the following people:
  • Mr. Gary L. Crocker M.B.A., MBA, Pres, Treasurer, Principal Financial Officer, Principal Accounting Officer, CEO & Chairman (Age 69, Pay $76k)
  • Dr. Ulrik B. Nielsen, Co-Founder & Independent Director (Age 49, Pay $67.62k)
  • Dr. Anthony J. Sinskey Ph.D., Sc.D., Co-Founder and Scientific Advisor (Age 81)
  • Geoffrey Grande C.F.A., Sr. Director of Communications
  • Ms. Ellen K. Forest, Head of HR (Age 57)
  • Dr. Fazal R. Khan Ph.D., Sr. VP of Manufacturing (Age 71)
  • Dr. Daryl C. Drummond Ph.D., Head of Research (Age 52)
  • Mr. Timothy R. Surgenor, Sec. (Age 61)

What is Merrimack Pharmaceuticals' stock symbol?

Merrimack Pharmaceuticals trades on the NASDAQ under the ticker symbol "MACK."

How do I buy shares of Merrimack Pharmaceuticals?

Shares of MACK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Merrimack Pharmaceuticals' stock price today?

One share of MACK stock can currently be purchased for approximately $7.56.

How big of a company is Merrimack Pharmaceuticals?

Merrimack Pharmaceuticals has a market capitalization of $101.15 million. Merrimack Pharmaceuticals employs 27 workers across the globe.

What is Merrimack Pharmaceuticals' official website?

The official website for Merrimack Pharmaceuticals is www.merrimackpharma.com.

How can I contact Merrimack Pharmaceuticals?

Merrimack Pharmaceuticals' mailing address is ONE BROADWAY 14TH FLOOR, CAMBRIDGE MA, 02142. The biopharmaceutical company can be reached via phone at 617-441-1000 or via email at [email protected]

This page was last updated on 1/23/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.